Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,393 | 11,219 | 5,398 | 7,466 | 14,492 |
| Receivables | 40,370 | 35,727 | 35,827 | 37,127 | 33,365 |
| Income taxes - deferred | 1,931 | 1,668 | 1,668 | 1,668 | 1,669 |
| Other current assets | 5,312 | 4,971 | 5,294 | 6,949 | 10,776 |
| TOTAL | $68,651 | $57,762 | $50,106 | $55,787 | $63,379 |
| Non-Current Assets | |||||
| PPE Net | 533,322 | 432,836 | 326,871 | 312,409 | 299,775 |
| Investments And Advances | 7,886 | 8,598 | 8,631 | 4,265 | 5,844 |
| Intangibles | 3,593 | 3,966 | 4,174 | 4,639 | 5,085 |
| TOTAL | $544,801 | $445,400 | $339,676 | $321,313 | $310,704 |
| Total Assets | $613,452 | $503,162 | $389,782 | $377,100 | $374,083 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24,800 | 800 | 800 | 800 | 800 |
| Accounts payable and accrued liabilities | 113,791 | 99,477 | 51,811 | 31,159 | 25,975 |
| Accrued Expenses | 5,408 | 4,743 | 2,743 | 2,215 | 3,638 |
| TOTAL | $154,161 | $114,372 | $63,731 | $42,841 | $38,451 |
| Non-Current Liabilities | |||||
| Long Term Debt | 220,800 | 185,500 | 150,100 | 160,300 | 161,500 |
| Deferred Revenues | 5,724 | 4,612 | 4,163 | 4,209 | 4,225 |
| Other Non-Current Liabilities | 230 | -49 | 0 | 0 | 0 |
| TOTAL | $261,617 | $224,141 | $190,535 | $203,030 | $206,534 |
| Total Liabilities | $415,778 | $338,513 | $254,266 | $245,871 | $244,985 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,295 | 17,914 | 17,914 | 17,917 | 17,917 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 55,043 | 44,546 | 35,385 | 29,709 | 26,660 |
| Other shareholders' equity | 15,565 | 15,688 | -4,052 | -2,434 | -1,248 |
| TOTAL | $197,674 | $164,649 | $135,516 | $131,229 | $129,098 |
| Total Liabilities And Equity | $613,452 | $503,162 | $389,782 | $377,100 | $374,083 |